期刊文献+

可溶性上皮钙黏素检测在HBV感染相关疾病中的应用研究 被引量:2

Value of soluble E-cadherin as a serum biomarker in detecting HBV-related liver diseases
下载PDF
导出
摘要 目的探讨血清可溶性上皮钙黏素(sE-cadherin)检测在乙型肝炎病毒(HBV)感染相关疾病中的应用价值。方法采用酶联免疫吸附测定(ELISA)试剂盒分别检测了113例慢性乙型肝炎(CHB)、101例乙肝后硬化(Cirrhosis),75例肝细胞癌(HCC)患者和125例对照组血清中的sE-cadherin和干扰素-γ(IFN-γ)水平。结果 HBV相关疾病患者血清sE-cadherin水平均高于对照组,差异有统计学意义(P<0.05)。CHB和Cirrhosis患者血清sE-cadherin水平与INF-γ、丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)水平呈正相关(P<0.05)。HCC患者血清sE-cadherin水平与ALT、AST水平呈正相关(P<0.05)。结论 sE-cadherin可能是评估HBV相关疾病进程的一个重要血清标志物。 Objective To investigate the value of serum sE-cadherin in detecting hepatitis B virus(HBV)-related diseases.Methods Totally 113 patients with chronic hepatitis B,101 patients with HBV-related cirrhosis,75 patients with hepatocellular carcinoma and 125 healthy individuals were selected as subjects.Levels of serum sE-cadherin and interferon-γ(IFN-γ)were measured by using enzyme linked immunoabsortent assay(ELISA)and compared between the groups.Results sE-cadherin levels in patients with HBV-related diseases were significantly higher than that in healthy controls(P〈0.05).The levels of serum sE-cadherin were positively correlated with the serum levels of IFN-γ,alanine transarminase(ALT)and aspartate aminotransferase(AST)in patients with chronic hepatitis B and cirrhosis patients.In patients with hepatocellular carcinoma,levels of serum sE-cadherin were only positively correlated with the serum levels of ALT and AST(P〈0.05).Conclusion Serum sE-cadherin levels might be an important indicator of the pathogenesis in progression of HBV-related diseases.
出处 《检验医学与临床》 CAS 2016年第21期2992-2993,2997,共3页 Laboratory Medicine and Clinic
基金 重庆市卫生和计划生育委员会医学科研项目(2013-2-046)
关键词 可溶性E-钙粘蛋白 慢性乙型肝炎 肝硬化 肝细胞癌 细胞因子 sE-cadherin chronic hepatitis B cirrhosis hepatocellular carcinoma cytokine
  • 相关文献

参考文献13

  • 1Lecuit T, Yap AS. E-cadherin junctions as active mechani-cal integrators in tissue dynamics[J]. Nat Cell Biol,2015,17(5):533-539.
  • 2David JM, Rajasekaran AK. Dishonorable discharge: theoncogenic roles of cleaved E-cadherin fragments [ J ].Cancer Res,2012,72(12) :2917-2923.
  • 3Hu QP,Kuang JY.Yang QK,et al. Beyond a tumor sup-pressor: Soluble E-cadherin promotes the progression ofcancer[J]. Int J Cancer,2016,138(12) :2804-2812.
  • 4Brouxhon SM, Kyrkanides S,Teng X,et al. Soluble E-cadherin:a critical oncogene modulating receptor tyrosinekinases,MAPK and PI3K/Akt/mTOR signaling[J]. On-cogene ,2014,33(2):225-235.
  • 5王贵强,王福生,成军,任红,庄辉,孙剑,李杰,李兰娟,孟庆华,赵景民,段钟平,侯金林,贾继东,唐红,盛吉芳,彭劼,鲁凤民,谢青,魏来.慢性乙型肝炎防治指南(2015年版)[J].中国肝脏病杂志(电子版),2015,7(3):1-18. 被引量:462
  • 6Lavanchy D. Hepatitis B virus epidemiology, disease bur-den, treatment, and current and emerging prevention andcontrol measures[J]. J Viral Hepat,2004,11(2) :97-107.
  • 7Ganem D,Prince AM. Hepatitis B virus infection-naturalhistory and clinical consequences[J]. N Engl J Med,2004,350(11):1118-1129.
  • 8Ye B, Liu X,Li X,et al. T-cell exhaustion in chronic hepa-titis B infection: current knowledge and clinical signifi-cance[J]. Cell Death Dis,2015 ,6(3) :el694.
  • 9Pittard AJ,Banks RE,Galley HF,et al. Soluble E-cadher-in concentrations in patients with systemic inflammatoryresponse syndrome and multiorgan dysfunction syndrome[J]. Br J Anaesth,1996,76(5) :629-631.
  • 10Sewpaul A,French JJ,Khoo TK,et al. Soluble E-cadher-in: an early marker of severity in acute pancreatitis [J].HPB Surg,2009:397375.

二级参考文献16

共引文献461

同被引文献2

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部